BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17257397)

  • 1. Mandatory chromosomal segment balance in aneuploid tumor cells.
    Kost-Alimova M; Darai-Ramqvist E; Yau WL; Sandlund A; Fedorova L; Yang Y; Kholodnyuk I; Cheng Y; Li Lung M; Stanbridge E; Klein G; Imreh S
    BMC Cancer; 2007 Jan; 7():21. PubMed ID: 17257397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microcell-mediated chromosome transfer provides evidence that polysomy promotes structural instability in tumor cell chromosomes through asynchronous replication and breakage within late-replicating regions.
    Kost-Alimova M; Fedorova L; Yang Y; Klein G; Imreh S
    Genes Chromosomes Cancer; 2004 Aug; 40(4):316-24. PubMed ID: 15188454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
    Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of normal chromosome 3p modulates the tumorigenicity of a human renal cell carcinoma cell line YCR.
    Shimizu M; Yokota J; Mori N; Shuin T; Shinoda M; Terada M; Oshimura M
    Oncogene; 1990 Feb; 5(2):185-94. PubMed ID: 1969617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential elimination of 3p and retention of 3q segments in human/mouse microcell hybrids during tumor growth.
    Imreh S; Kost-Alimova M; Kholodnyuk I; Yang Y; Szeles A; Kiss H; Liu Y; Foster K; Zabarovsky E; Stanbridge E; Klein G
    Genes Chromosomes Cancer; 1997 Nov; 20(3):224-33. PubMed ID: 9365829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monochromosome transfer provides functional evidence for growth-suppressive genes on chromosome 14 in nasopharyngeal carcinoma.
    Cheng Y; Ko JM; Lung HL; Lo PH; Stanbridge EJ; Lung ML
    Genes Chromosomes Cancer; 2003 Aug; 37(4):359-68. PubMed ID: 12800147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice.
    Yang Y; Kost-Alimova M; Ingvarsson S; Qianhui Q; Kiss H; Szeles A; Kholodnyuk I; Cuthbert A; Klein G; Imreh S
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1136-41. PubMed ID: 11158607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer of human chromosome 3 to an ovarian carcinoma cell line identifies three regions on 3p involved in ovarian cancer.
    Rimessi P; Gualandi F; Morelli C; Trabanelli C; Wu Q; Possati L; Montesi M; Barrett JC; Barbanti-Brodano G
    Oncogene; 1994 Dec; 9(12):3467-74. PubMed ID: 7970706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of 3p, 5p, and 3q in two nasopharyngeal carcinoma cell lines, using region-specific multiplex fluorescence in situ hybridization probes.
    Tjia WM; Sham JS; Hu L; Tai AL; Guan XY
    Cancer Genet Cytogenet; 2005 Apr; 158(1):61-6. PubMed ID: 15771906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human/mouse microcell hybrid based elimination test reduces the putative tumor suppressor region at 3p21.3 to 1.6 cM.
    Szeles A; Yang Y; Sandlund AM; Kholodnyuk I; Kiss H; Kost-Alimova M; Zabarovsky ER; Stanbridge E; Klein G; Imreh S
    Genes Chromosomes Cancer; 1997 Dec; 20(4):329-36. PubMed ID: 9408748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 3p21.3 region is preferentially eliminated from human chromosome 3/mouse microcell hybrids during tumor growth in SCID mice.
    Kholodnyuk I; Kost-Alimova M; Kashuba V; Gizatulin R; Szeles A; Stanbridge EJ; Zabarovsky ER; Klein G; Imreh S
    Genes Chromosomes Cancer; 1997 Mar; 18(3):200-11. PubMed ID: 9071573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma.
    Hu LF; Eiriksdottir G; Lebedeva T; Kholodniouk I; Alimov A; Chen F; Luo Y; Zabarovsky ER; Ingvarsson S; Klein G; Ernberg I
    Genes Chromosomes Cancer; 1996 Oct; 17(2):118-26. PubMed ID: 8913729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 1-Mb PAC contig spanning the common eliminated region 1 (CER1) in microcell hybrid-derived SCID tumors.
    Yang Y; Kiss H; Kost-Alimova M; Kedra D; Fransson I; Seroussi E; Li J; Szeles A; Kholodnyuk I; Imreh MP; Fodor K; Hadlaczky G; Klein G; Dumanski JP; Imreh S
    Genomics; 1999 Dec; 62(2):147-55. PubMed ID: 10610706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel metastasis-suppressor region on human chromosome 12.
    Luu HH; Zagaja GP; Dubauskas Z; Chen SL; Smith RC; Watabe K; Ichikawa Y; Ichikawa T; Davis EM; Le Beau MM; Rinker-Schaeffer CW
    Cancer Res; 1998 Aug; 58(16):3561-5. PubMed ID: 9721861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling non-random deletions in cancer.
    Kost-Alimova M; Imreh S
    Semin Cancer Biol; 2007 Feb; 17(1):19-30. PubMed ID: 17174104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3q26 Amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study.
    Pelosi G; Del Curto B; Trubia M; Nicholson AG; Manzotti M; Veronesi G; Spaggiari L; Maisonneuve P; Pasini F; Terzi A; Iannucci A; Viale G
    Clin Cancer Res; 2007 Apr; 13(7):1995-2004. PubMed ID: 17404079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
    Cody NA; Shen Z; Ripeau JS; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
    Mol Carcinog; 2009 Dec; 48(12):1077-92. PubMed ID: 19347865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p.
    Cody NA; Ouellet V; Manderson EN; Quinn MC; Filali-Mouhim A; Tellis P; Zietarska M; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
    Oncogene; 2007 Jan; 26(4):618-32. PubMed ID: 16909122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.